EU-PEARL takes the floor in DIA EUROPE 2022 to share advances made in innovative clinical trials design

DIA EUROPE 2022 is to take place next 29-31 March in a hybrid format -in Brussels and online- under the title “Advancing Health Priorities”. EU-PEARL Consortium member Francesco Patalano (Novartis) will speak during the session “Accelerating Complex Innovative Clinical Trial Designs in Europe and Beyond” scheduled for Tuesday 29th to explain the progress made by the project in this area and discuss sustainable solutions. Claas Röhl (NF Kinder), representative of associated partner, NF Patients United and part of EU-PEARL’s Patient Advisory Group (PAG) will also intervene in this session.

Annette Bakker (Children’s Tumor Foundation) and Valentina Strammiello (European Patient Forum), also members of this IMI project, will participate in the sessions “Early Patient Engagement in Drug Development and Decision Making” and “HTAi Dialogue: the More the Merrier: Aligning Regulatory Decision-Making and Health Technology Assessment When Managing Uncertainty” respectively.

During DIA Europe2002 more than 230 speakers from the European Commission, EMA, National Authorities, Patient Representatives, Industry and Healthcare professionals will take the floor to discuss the future of healthcare product development from different perspectives.

Please find more information about the event here.